MedPath

The response of intravitreal bevacizumab in the treatment of intraocular neovascularizatio

Not Applicable
Conditions
Ocular neovascularization
Registration Number
JPRN-UMIN000009389
Lead Sponsor
Osaka University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Cr>3.0mg/dL unstable angina malignant arhythmia pregnant female

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath